Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;328:48 (3 January), doi:10.1136/bmj.328.7430.48
| The first 150 words of the full text of this article appear below. |
EDITORBell has done a great service in raising the urgency with which a strategic rethink of clinical research is needed.1 It is three years since very similar recommendations were published by Peckham's Foresight panel, including, for example, a national strategy for clinical trials,2 but rather than showing progress, during these years health science for practice has deteriorated further.
|
|
Credit: GEOFF TOMPKINSON/SPL
|
Efforts by the NHS, research councils, and health charities to plan together strategically have been undermined by a rogue stakeholder, the Higher Education Funding Council for England, which has been determined to do its own thing. As the council puts it, in its latest review, there is no similar mechanism for encouraging collaboration between higher education institutions and research organisations outside the health education sectorthat is, in health care.3 Whereas the NHS makes a massive contribution to teaching and learning for higher education, the Higher Education Funding
Woody Caan, professor of public health
APU, Chelmsford, Essex CM1 1SQ a.w.caan@apu.ac.uk